0 results for 'Venable'
The 2024 Am Law 100: Ranked by Revenue Per Lawyer
For the Am Law 100 as a whole, average revenue per lawyer, the metric that we've long regarded as the most reliable measure of a firm's financial health, increased by 4.9%. In 2023, eighty-five firms posted a gain in RPL.See How Pa. Firms Fared in The 2024 Am Law 100 Gross Revenue Ranking
Fifty-four firms posted gross revenue of $1 billion or more in 2023, four more than in 2022. Ninety firms reported gains in gross revenue.The 2024 Am Law 100: Ranked by Gross Revenue
Fifty-four firms posted gross revenue of $1 billion or more in 2023, four more than in 2022. Ninety firms reported gains in gross revenue.The 2024 Am Law 100: Ranked by Gross Revenue
Fifty-four firms posted gross revenue of $1 billion or more in 2023, four more than in 2022. Ninety firms reported gains in gross revenue.Firms Are Stuck With Abiding by New Anti-Secrecy Law, Even Though Judge Ruled It Unconstitutional
"Treasury's targets are those dubious LLCs without operations and employees that are holding shell companies hiding assets," said Snežana Gebauer, a partner at the compliance consulting firm StoneTurn.View more book results for the query "Venable"
An Early Look: The 2024 Am Law 200 Financials
This feed is continually updated. So bookmark it, check back regularly, and stay tuned for the Am Law 100 and Second Hundred reports coming soon.Health Care AI: The New Buzzword in a Shifting Legal Regime
Artificial intelligence has proliferated the health care sector, sparking litigation and increased regulatory activity. This article analyzes the impact of AI in health care and regulatory agencies' efforts to keep up—all against the backdrop of a potentially weakened 'Chevron' deference framework.IAPP Day 1: The Privacy Sector's Most Entertaining Data Privacy Governance Metaphors
The first day of the IAPP Governance Privacy Summit 2024 in Washington D.C. focused on the integration of data privacy governance strategies within companies and among regulators as well.Out of the Shadows: SEC Test Case To Bring 'Shadow Trading' Into Light
The SEC is now at trial in an enforcement action against former biopharma executive Matthew Panuwat related to "shadow trading" activities. The trial will not only be the first major test of the SEC's "shadow trading" legal theory before a jury, but will also have significant ramifications for in-house counsel and compliance teams on how to train their employees on trading practices.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
2024 Report: State of AI in Legal
Brought to you by Ironclad
Download Now
Blueprint for Successful Second Request Document Review
Brought to you by Integreon
Download Now
Employee Happiness Playbook: The 3 R's for Business Success in 2024
Brought to you by Amazing Workplace, Inc.
Download Now
The Positive Impact of AI at Small Law Firms: 4 Key Insights
Brought to you by LexisNexis®
Download Now